Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

Por Kümmel, S, Krocker, J, Kohls, A, Breitbach, G-P, Morack, G, Budner, M, Blohmer, J-U, Elling, D
Publicado em 2006

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

Por Al-Batran, S-E, Bischoff, J, von Minckwitz, G, Atmaca, A, Kleeberg, U, Meuthen, I, Morack, G, Lerbs, W, Hecker, D, Sehouli, J, Knuth, A, Jager, E
Publicado em 2006